Silexion Therapeutics Corp.
13F holders, Q3 2024 (September 30)5holders
$0.52avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding Silexion Therapeutics Corp. in their 13F filings. The largest holders were Wildcat Capital Management, LLC ($536K), HRT Financial LP ($47K) and Virtu Financial LLC ($14K).
- Company
- Silexion Therapeutics Corp.
- CUSIP
- G1281K106
- Latest filing quarter
- Q3 2024
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $613K |
| Exits | 0 | $0 |
Ownership 5 holders
| Wildcat Capital Management, LLC | 0.26% | New | 1,020,852 | $536K |
| HRT Financial LP | 0.00% | New | 89,970 | $47K |
| Virtu Financial LLC | 0.00% | New | 26,661 | $14K |
| Two Sigma Securities, LLC | 0.00% | New | 15,120 | $8K |
| UBS Group AG | 0.00% | New | 15,059 | $8K |
"% of holder's portfolio" is SILEXION THERAPEUTICS CORP's weight in each manager's 13F, not the share of Silexion Therapeutics Corp. the manager owns.